Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Asia-Pacific looks to grab increasing share of the global clinical trial market

CenterWatch : 07 February, 2008  (New Product)
A new report published by CenterWatch indicates that the Asia-Pacific region is grabbing an increasing share of the global clinical trial market, and with new regulatory changes across the region, has already been growing at more than 50 percent in recent years.
According to the new 160-plus page report from CenterWatch entitled ĎAsia- Pacific's Growing Role in Global Clinical Trials’ the Asia Pacific countries are tapping into their power as a bloc to boost their role in the expanding global clinical trials market.

The report contains the results from CenterWatch's first-ever survey of clinical researchers in the region. CenterWatch surveyed more than 156 investigative sites from more than a dozen countries in Asia Pacific. The survey revealed, among other results, the key role of electronic data capture (EDC) of clinical trial information in this region.

Highlights of the report include:

- Charts of survey results from CenterWatch's ground-breaking investigator survey of the region. Fifty charts with proprietary data are included.

- A pipeline of drugs in development in Asia-Pacific countries.

- Extensive interviews with executives from global pharmaceutical companies and contract research organizations (CRO) that have on-the-ground experience in the Asia-Pacific region.

- A breakdown of contract research organizations country-by-country.

The global CRO market has been a worldwide growth story and the Asia-Pacific region has been one of the hottest areas for this growth. The year 2007 saw more CRO mergers and acquisitions - 35 - than in any previous year since CenterWatch began tracking the market in the mid 1990s when contract research took off.

'More than half of those acquisitions were made to take advantage of the growth in global clinical trials. The largest CROs are strengthening their worldwide infrastructures. Some smaller and mid-sized CROs are looking to become global players to attain the size needed to be considered by big pharmaceutical companies for their large, global trials. Asia-Pacific was a hotbed of activity for clinical trials,' said Steve Zisson, editorial director of CenterWatch.

Sara Gambrill, senior editor at CenterWatch and author of the report, noted, 'Asia-Pacific is becoming an integral player in global drug development, and will be taking a leadership position on more global clinical trials projects.'
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   ¬© 2012 ProHealthServiceZone.com
Netgains Logo